KAILE EGGEMEYER: Open Payments
NPI 1588264493 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 84 payments from 19 companies in 2025. Trend: 2023 $45 · 2024 $1,251 · 2025 $1,519
Food & beverage: $1,519
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $379 |
| Phathom Pharmaceuticals, Inc. | 15 | $178 |
| Madrigal Pharmaceuticals | 7 | $135 |
| Janssen Biotech, Inc. | 5 | $128 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $82 |
| Ardelyx, Inc. | 4 | $72 |
| Novo Nordisk Inc | 4 | $71 |
| Ipsen Biopharmaceuticals, Inc | 3 | $53 |
| GENZYME CORPORATION | 2 | $51 |
Products named: VOQUEZNA, RINVOQ, REZDIFFRA, LINZESS, TREMFYA, XIFAXAN, ENTYVIO, DUPIXENT.
Industry payments across IL — which companies pay providers there.
